AtriCure | ATRC - 营业利润

金融业

USD

USD 676.64M

现金及等价物

USD 167.79M

USD 34.98M

USD 345.53M

USD 81.92M

USD 71.78M

股息收益率

0

USD 9.67M

USD 27.29M

1.3K

EPS每股收益

USD 0.18

股本和储备

USD 516.43M

USD 109.31M

债务利息支出

USD 1.21M

USD 1.25M

USD 61M

USD 1.96B

USD 8.96M

USD 143.94M

USD 9.67M

普通股股本

USD 50.64M

129.01

USD 394K

USD 153.6M

销售和管理费用

USD 82.56M

USD 83.93M

贸易债权人

USD 78.74M

应收帐款人

USD 79.98M

	营业利润	更改		日
Abbott	USD 2.13B		281M	2026-06
Artivion	USD 4.79M		6.85M	2025-12
AtriCure	USD 9.66M		9.14M	2026-06
Baxter International	USD 276M		210M	2026-06
Becton, Dickinson and Co.	USD 627M		36M	2026-03
Boston Scientific	USD 1.24B		190M	2026-06
Cooper Companies	USD -31M		243.8M	2026-03
Dexcom	USD 318.3M		63M	2026-06
Edwards Lifesciences	USD 519.5M		4.8M	2026-06
Globus Medical	USD 164M		17.31M	2026-03
Inogen	USD -7.79M		728K	2024-09
Insulet	USD 122M		24.3M	2026-03
Integra LifeSciences	USD 41.29M		29.82M	2026-06
Intuitive Surgical	USD 977.6M		117.9M	2026-06
J&J	USD 7.48B		860M	2026-06
Medtronic	USD 2.09B		354M	2026-03
Merit Medical Systems	USD 60.4M		16.25M	2026-06
ResMed	USD 505.67M		8.07M	2026-03
Stryker	USD 1.1B		867M	2026-03
Tandem Diabetes Care	USD 8.29M		31.16M	2025-12
Teleflex	USD 37.03M		686K	2026-03
Zimmer Biomet Holdings	USD 395.1M		92.2M	2026-03